Allentown, a leader in providing life science solutions, has announced a significant development in its business strategy with the acquisition of ClorDiSys. This move is set to enhance Allentown’s footprint in the global biomedical research and life science markets, reinforcing its commitment to innovation and customer-centric services.

Charles Simmons, CEO of Allentown, articulated the strategic vision behind the acquisition. “We’re excited to integrate ClorDiSys into our operations. This acquisition aligns with our strategy to broaden our offerings in high-science equipment and services in the life science industries,” Simmons stated. Dane Kmetz, Vice President of M&A and Business Development at Allentown, echoed this sentiment, highlighting the importance of integrating high-performing teams and customer-centric solutions into their growth strategy.

ClorDiSys, a family-owned company founded in 2001, has made significant strides in decontamination equipment and services. They have become a leader in their field, providing innovative solutions worldwide across various industries. The company’s commitment to quality and customer satisfaction has been a key factor in its success.

Paul Lorcheim, Director and Co-Founder of ClorDiSys, expressed enthusiasm for the acquisition. “Joining forces with Allentown enables us to extend our reach and bring our advanced sterilization technology to more research institutions and industries,” Lorcheim said. He emphasized ClorDiSys’ expansion into the medical device sterilization market, highlighting the efficiency and environmental benefits of their chlorine dioxide gas sterilization technology over traditional methods like Ethylene Oxide (EtO).

With this acquisition, Allentown will incorporate ClorDiSys’ decontamination, disinfection, and sterilization services into its solution offerings. This addition will close the loop on vital vivarium services provided by Allentown, ensuring comprehensive support for essential research equipment. This holistic approach consolidates customer interactions with a single solutions provider, enhancing the innovative solutions offered by Allentown.

This acquisition aligns with Allentown’s continuous commitment to innovation and expanding its scientific service offerings, significantly impacting the vivarium and broader life science markets.

  Allentown, Charles Simmons, ClorDiSys, Dane Kmetz, Paul Lorcheim